Linked videos:
• What to do if you get ...
• Vioxx and finasteride,...
• Why dutasteride stops ...
Sources:
1. Zhou Z, Cui Y, Wu J, Jin H. Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine. 2020;20(2):1566-1574. doi:10.3892/etm.2020.8851
2. Lephart ED. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment. Neurobiol Aging. 1995;16(4):647-650. doi:10.1016/0197-4580(95)98115-5
3. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554.
4. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. European Journal of Endocrinology. 2001;145(6):669-679. doi:10.1530/eje.0.1450669
5. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330
6. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. doi:10.1016/j.jaad.2006.05.007
7. Mondaini N, Gontero P, Giubilei G, et al. Finasteride 5mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon? The Journal of Sexual Medicine. 2007;4(6):1708-1712. doi:10.1111/j.1743-6109.2007.00563.x
8. Traish AM. 5α-Reductases In Human Physiology: an Unfolding Story. Endocrine Practice. 2012;18(6):965-975. doi:10.4158/EP12108.RA
9. Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. IJDVL. 2014;80:521. doi:10.4103/0378-6323.144162
10. Jung JY, Yeon JH, Choi JW, et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatology. 2014;53(11):1351-1357. doi:10.1111/ijd.12060
11. Martinez PE, Rubinow DR, Nieman LK, et al. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology. 2016;41(4):1093-1102. doi:10.1038/npp.2015.246
12. Shanshanwal SJS, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. IJDVL. 2017;83:47. doi:10.4103/0378-6323.188652
13. Swerdloff RS, Dudley RE, Page ST, Wang C, Salameh WA. Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocr Rev. 2017;38(3):220-254. doi:10.1210/er.2016-1067
14. Andy G, John M, Mirna S, et al. Controversies in the treatment of androgenetic alopecia: The history of finasteride. Dermatologic Therapy. 2019;32(2):e12647. doi:10.1111/dth.12647
15. Choi GS, Sim WY, Kang H, et al. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. Ann Dermatol. 2022;34(5):349-359. doi:10.5021/ad.22.027
16. Escamilla-Cruz M, Magaña M, Escandón-Perez S, Bello-Chavolla OY. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. Dermatol Ther (Heidelb). 2023;13(8):1721-1731. doi:10.1007/s13555-023-00974-4
17. Laanani M, Weill A, Jollant F, Zureik M, Dray-Spira R. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study. Sci Rep. 2023;13(1):5308. doi:10.1038/s41598-023-32356-3
18. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Sig Transduct Target Ther. 2023;8(1):1-27. doi:10.1038/s41392-023-01481-w
19. Almudaimeegh A, AlMutairi H, AlTassan F, AlQuraishi Y, Nagshabandi KN. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. Published online April 12, 2024. doi:10.4081/dr.2024.9909
Негізгі бет Тәжірибелік нұсқаулар және стиль Why don't we ever hear about Post-Dutasteride Syndrome?
Пікірлер: 920